Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 38% ± 21% | |
peripheral blood | 15 studies | 26% ± 9% | |
lung | 8 studies | 24% ± 7% | |
eye | 8 studies | 38% ± 21% | |
liver | 5 studies | 21% ± 8% | |
bone marrow | 4 studies | 21% ± 4% | |
heart | 4 studies | 20% ± 4% | |
adipose | 4 studies | 26% ± 5% | |
kidney | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2874.62 | 1444 / 1445 | 99% | 8.84 | 182 / 183 |
skin | 100% | 4953.36 | 1809 / 1809 | 99% | 43.41 | 467 / 472 |
thymus | 100% | 3160.55 | 652 / 653 | 98% | 10.70 | 592 / 605 |
brain | 97% | 2607.64 | 2561 / 2642 | 99% | 8.47 | 699 / 705 |
breast | 100% | 5395.69 | 459 / 459 | 96% | 9.57 | 1073 / 1118 |
lung | 100% | 5076.07 | 578 / 578 | 92% | 5.93 | 1059 / 1155 |
uterus | 100% | 3770.57 | 170 / 170 | 84% | 4.67 | 385 / 459 |
prostate | 100% | 2701.29 | 245 / 245 | 80% | 3.34 | 400 / 502 |
pancreas | 86% | 981.23 | 281 / 328 | 93% | 5.19 | 165 / 178 |
kidney | 98% | 1529.74 | 87 / 89 | 79% | 4.67 | 711 / 901 |
bladder | 100% | 3637.52 | 21 / 21 | 75% | 3.96 | 377 / 504 |
stomach | 100% | 2501.53 | 358 / 359 | 74% | 3.91 | 213 / 286 |
adrenal gland | 99% | 1848.58 | 256 / 258 | 74% | 3.73 | 171 / 230 |
intestine | 100% | 3022.09 | 966 / 966 | 60% | 2.60 | 317 / 527 |
liver | 97% | 1261.33 | 219 / 226 | 57% | 2.16 | 230 / 406 |
ovary | 100% | 2871.76 | 180 / 180 | 29% | 0.85 | 125 / 430 |
adipose | 100% | 5202.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3481.41 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 5608.41 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6226.89 | 922 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 4.38 | 42 / 45 |
heart | 87% | 1221.17 | 751 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 7.34 | 63 / 80 |
lymph node | 0% | 0 | 0 / 0 | 76% | 6.61 | 22 / 29 |
muscle | 76% | 879.33 | 609 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051607 | Biological process | defense response to virus |
GO_0033364 | Biological process | mast cell secretory granule organization |
GO_0015031 | Biological process | protein transport |
GO_0008104 | Biological process | protein localization |
GO_0042742 | Biological process | defense response to bacterium |
GO_0032510 | Biological process | endosome to lysosome transport via multivesicular body sorting pathway |
GO_0030595 | Biological process | leukocyte chemotaxis |
GO_0032438 | Biological process | melanosome organization |
GO_0043473 | Biological process | pigmentation |
GO_0006909 | Biological process | phagocytosis |
GO_0042832 | Biological process | defense response to protozoan |
GO_0042267 | Biological process | natural killer cell mediated cytotoxicity |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0016020 | Cellular component | membrane |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LYST |
Protein name | LYST protein Lysosomal-trafficking regulator (Beige homolog) Lysosomal trafficking regulator |
Synonyms | CHS1 CHS |
Description | FUNCTION: Adapter protein that regulates and/or fission of intracellular vesicles such as lysosomes . Might regulate trafficking of effectors involved in exocytosis . In cytotoxic T-cells and natural killer (NK) cells, has role in the regulation of size, number and exocytosis of lytic granules . In macrophages and dendritic cells, regulates phagosome maturation by controlling the conversion of early phagosomal compartments into late phagosomes (By similarity). In macrophages and dendritic cells, specifically involved in TLR3- and TLR4-induced production of pro-inflammatory cytokines by regulating the endosomal TLR3- TICAM1/TRIF and TLR4- TICAM1/TRIF signaling pathways . . |
Accessions | A0A8V8TKU7 A0A8V8TM69 ENST00000468626.2 A0A8V8TKT6 B7ZMN7 A0A8V8TL78 A0A8V8TME5 Q99698 ENST00000697235.1 A0A8V8TMC0 ENST00000487530.2 ENST00000697241.1 ENST00000697178.1 ENST00000697182.1 ENST00000489585.5 [Q99698-2] ENST00000697237.1 A0A8V8TM32 ENST00000697183.1 H7C4F5 A0A8V8TL83 A0A8V8TKS8 ENST00000389793.7 [Q99698-1] ENST00000468107.5 A0A8V8TL52 ENST00000697242.1 ENST00000697236.1 ENST00000475277.2 ENST00000697240.1 A0A8V8TMB4 ENST00000697184.1 ENST00000697180.1 ENST00000697181.1 A0A8V8TKW4 ENST00000461526.2 A0A8V8TL58 |